brought together international experts in histocompatibility, transplantation and immunogenetics to discuss emerging challenges and future directions in the field.
The first day focused on antibody-mediated risk in transplantation and the evolving role of molecular tools. Sessions covered the impact of non-HLA antibodies on outcomes of unrelated donor hematopoietic stem cell transplantation and practical aspects of non-HLA antibody testing, followed by a lecture on the role of memory B cells in kidney transplantation. A series of talks then addressed standardization and interpretation of HLA antibody testing: a comparative assessment of mean fluorescence intensity across laboratories and platforms, challenging antibody case discussions, and an introduction to MatchX and molecular mismatching. The afternoon was dedicated to the International HLA and Immunogenetics Workshop (IHIWS), with an update on HLA serological antigen designations in 2025, lessons learned on HLA epitopes, and an exploration of the immunogenetics of aging with a specific focus on KIR.
The second day highlighted precision risk assessment and technological innovation. Presentations examined how to navigate the spectrum of immunological risk in transplantation and outlined the future of HLA typing with next-generation sequencing. Further sessions explored immunophenotypic and immunogenetic profiles in women with reproductive failure, shared single-center experience with the Omixon NanoTYPE HLA NGS assay, and compared Luminex 200 and FLEXMAP 3D platforms for optimizing HLA antibody identification. The program concluded with real-world experience on fully automated HLA antibody testing and its impact on laboratory workflows.
The seminar’s rich scientific content and highly interactive discussions underscored its role as a dedicated forum for advancing HLA and immunogenetics, strengthening collaboration between transplant centers, immunogenetics laboratories and industry partners. We thank all speakers and participants for their contributions and look forward to building on this success in future editions of the Werfen HLA & Immunogenetics Seminar.